Member of the board of Exor N.V. and of HEC Paris Business
Group chief financial officer, executive board member, of
Heineken N.V, 2015-2021.
Group chief financial officer,
executive board member, at JCDecaux SA, 2010-2015.
strategic officer, chief financial officer and deputy chief
financial officer at Sanofi Aventis SA, 1996-2010.
Considered independent under the Danish Recommendations on
Member of the Board of Directors
since March 2019. Most recently elected in 2021 for a term of one
Member of the Audit Committee since March 2019 and
Chair of the Committee since March 2021. The Board has designated Ms
Debroux as financial expert as defined by the US Securities and
Exchange Commission (SEC) and assessed that Ms Debroux qualifies as
independent pursuant to the US Securities Exchange Act. The Board
assessed that Ms Debroux has competences in accounting and auditing
as required by the Danish Act on Approved Auditors and Audit
Member of the Remuneration Committee since March
Global corporate leadership
Healthcare and pharma
Finance & accounting
development, M&A and external innovation sourcing
Environmental, social and governance
1992: Master Degree, HEC Paris, Ecoles des Hautes Etudes
French, born 1969. Female.
NOVO NORDISK HQ
Novo Nordisk A/S Novo Allé 1 2880 Bagsværd
Denmark +45-4444-8888 CVR-no. 24256790